FDA Approved Medical Products for:

Cutaneous T-cell lymphoma

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Romidepsin
Trade Name
(Manufacturer Name)
Istodax
(Gloucester Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy
More Information about this product Drug Information Portal

Generic Name Denileukin diftitox
Trade Name
(Manufacturer Name)
Ontak®
(Eisai Medical Research, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor.
More Information about this product Drug Information Portal

Generic Name Bexarotene
Trade Name
(Manufacturer Name)
Targretin® (topical)
(Eisai Medical Research, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
More Information about this product Drug Information Portal
Medline Plus Health Information